Two separate bipartisan groups of U.S. senators sent letters to members of President Donald Trump’s Cabinet about expanding research on the medical benefits of marijuana on Thursday.
One letter, sent to Robert Wilkie, the head of the U.S. Department of Veterans Affairs (VA), encouraged the department to begin large-scale, clinical trials on the potential medical benefits of cannabis for veterans suffering from conditions such as post-traumatic stress disorder (PTSD) or chronic pain.
The other, sent to Attorney General Jeff Sessions, called for an increase in the number of federally approved manufacturers producing marijuana for research purposes.
The letter to Wilkie—signed by Sens. Jon Tester (D-MT) and Dan Sullivan (R-AK), as well as Reps. Phil Roe (R-TN) and Tim Walz (D-MN)—emphasized that the VA possesses the authority to conduct studies on marijuana’s health benefits and risks.
“The Department of Veterans Affairs (VA) is already conducting multiple small-scale studies into the potential health benefits of medicinal cannabis, and we believe VA has the authority, ability and capacity to carry out such a study,” the lawmakers, who are the chairmen and ranking members of the House and Senate veterans affairs committees, wrote. “Many of our nation’s veterans already use medicinal cannabis, and they deserve to have full knowledge of the potential benefits and side effects of this alternative therapy.”
“We strongly encourage VA to take its cues from veterans, who, according to The American Legion’s survey of its membership, overwhelmingly support research into medicinal cannabis. We, and all of our nation’s veterans, look forward to your prompt response.”
Marijuana research and access for veterans is an increasingly bipartisan issue, with lawmakers making repeated calls for reform to allow the veteran community to use cannabis as an alternative treatment option.
In April, Walz and Roe introduced legislation that would encourage the VA to “conduct and support research relating to the efficacy and safety” of cannabis. The following month, the proposal became the first-ever standalone marijuana reform bill to be approved by a congressional committee.
Additionally, the VA has seen internal pressure to green-light medical marijuana research. But the department has been slow to meet this growing demand.
Earlier this year, the VA clarified its policy to note that it can, in fact, look into potential medical applications of cannabis for veterans suffering from various conditions—after repeatedly claiming that federal law prohibited such activity. Still, the VA continues to prohibit its doctors from recommending medical cannabis to veterans.
The other letter, to Sessions, focuses on the need to increase manufacturing of marijuana from federally approved sources.
Sens. Orrin Hatch (R-UT) and Kamala Harris (D-CA) wrote to follow up on an earlier inquiry about the Department of Justice’s reluctance to approve additional cultivators of cannabis to be used in scientific research.
The senators cited a number of federal agencies and administration officials who’ve also expressed interest in expanding marijuana manufacturing in order to conduct further research.
“Marijuana’s impacts are being felt every day across the country—with or without research,” they wrote. “It is imperative that our nation’s brightest scientists have access to diverse types of federally-approved, research-grade marijuana to research both its adverse and therapeutic effects.”
The bipartisan duo sent a similar letter to Sessions in April, but he never wrote back.
“More than four months have elapsed, and it is troubling that we have not yet received a written response.”
Separately last month, a broader group of senators also wrote to the attorney general to request that his department stop blocking approvals of applications to grow research-grade cannabis.
“Such research is the critical foundation of sound policymaking that puts public health and safety first,” Hatch and Harris wrote in the new letter.
California Gov. Jerry Brown Keeps Saying Mean Things About Marijuana Consumers
During his two stints as California governor—between 1975 and 1983, and 2011 and next January, when he is termed out and may finally retire from almost 50 years of public life—Jerry Brown has become known for several character traits.
He is frugal, to the point of parsimony. He is attentive to issues that are way out there. He is concerned about climate change. And he cannot stop making negative, non-germane non sequiturs about marijuana, his state’s biggest cash crop.
In 2014, he suggested that neither California nor the United States could be a great economic power if marijuana was legalized, thanks to the shiftiness of “the potheads.”
“The world’s pretty dangerous, very competitive,” he said during an appearance on NBC’s Meet The Press. “I think we need to stay alert, if not 24 hours a day, more than some of the potheads might be able to put together.”
Giving his reasoning why he opposed marijuana legalization, he mused, “how many people can get stoned and still have a great state or a great nation?”
Now, in a New York Times profile published on Tuesday, while speaking on the subject of climate change, Brown reached deep into his pocket for a very off-topic cannabis-themed barb.
“We either do nothing and smoke marijuana because it’s legalized, or we put our shoulder to the plow and do everything we can,” he told the paper on a recent afternoon (one of 23 interviews he gave that same day, according to the Times). “I don’t know if I’m an optimist. I’m a realist.”
Links between recreational marijuana use and some vague “dumbing-down” of the populace are unfounded, and are reminiscent of the spurious, race-baiting tactics employed by former drug czar Harry Anslinger.
The source of Brown’s opprobrium towards marijuana is not immediately clear.
Before his election in 2010, Brown offered laconic yet incoherent reasoning for his adamant anti-legalization stance.
“You know, the number one drug on the street is marijuana. The cartels are increasingly taking over. This is a serious problem,” he told an interviewer with GQ.
(At the time, California had a thriving medical cannabis industry. Legalized marijuana was later found to compel drug-traffickers to exit trade in the drug and seek other forms of income.)
“I think it’s more prudent for California not to embrace a legalization strategy,” he added. “I don’t think fostering chemicals is a smart move.”
He declined to engage with the interviewer when asked if he’d support a policy of prohibiting alcohol.
Brown’s stance puts the 80-year-old at odds with most of his fellow California Democrats—chief among whom must be Lt. Gov. Gavin Newsom.
After opposing marijuana legalization in 2010, Newsom quickly hopped on board the cannabis bandwagon following Colorado and Washington’s votes to end cannabis prohibition in 2012, and was the most prominent political backer of 2016’s Prop. 64, which legalized recreational marijuana in California.
Newsom briefly mounted a bid for California governor a decade ago before he was boxed out by the better-funded and better-prepared elder statesman.
In recent years, Brown did eventually sign into law a package of bills that set up a regulated and taxed commercial cannabis industry in the state. But his outdated Reefer Madness views about people who consume marijuana seem to persist, if this week’s Times interview is any indication.
Photo courtesy of Bob Tilden.
Legalizing Psilocybin Could Be The Next Frontier In Drug Policy Reform After Marijuana
Drug policy reform isn’t likely to end with marijuana legalization—and if you’re wondering what the next step in the broader movement could be, it’s worth looking into psilocybin, the active ingredient in “magic mushrooms.”
Earlier this month, state- and city-level campaigns to change psilocybin laws made small advancements. Organizers in Denver submitted two initiatives to decriminalize the psychedelic compound, which would appear on a citywide ballot in May 2019 if both or either receive enough signatures.
And in Oregon, a measure that would legalize psilocybin-assisted treatment entered the signature gathering stage. That measure would appear on a state ballot in 2020 if the effort succeeds.
“We’re excited to gather signatures in support of establishing a community-based service framework, in which licensed providers, along with licensed producers of psilocybin mushrooms, can blaze new trails in Oregon in accordance with evolving practice standards,” psychotherapist Tom Eckert, who is a chief petitioner for the measure, said in a press release.
Though there’s still a lot of work to do on the marijuana reform front—and advocates haven’t exactly joined arms with the psilocybin movement yet—the efforts share several parallels. For example, both cannabis and psilocybin are federally banned as Schedule I drugs, meaning the government considers them to have a high potential for abuse and to be medically useless.
Research disputes that position for both substances. While an admittedly larger body of research has demonstrated various therapeutic benefits of marijuana, several studies have found compelling evidence that psilocybin can provide relief for individuals suffering from conditions such as depression and addiction—and research is ongoing.
“To be clear, there’s no scientific basis for psilocybin’s continued inclusion on Schedule I,” Angela Bacca, a strategist for the Psilocybin Service Initiative of Oregon, said. “It is imperative we change the law to match the reality and science because people are suffering who could otherwise benefit from this safe and uniquely effective service.”
Neither the Denver nor Oregon measures would create a legal retail system for psilocybin, as has been seen throughout the U.S. for marijuana. And in Denver, organizers submitted two separate decriminalization initiatives in order to test the waters, seeing if there’d be enough support to include cultivation in the language of their primary decriminalization measure.
If that initiative fails, the group Denver for Psilocybin will put their energy toward a similar initiative that simply decriminalizes low-level possession and personal use.
“It’s a natural right. It’s a human right,” Kevin Matthews, campaign director for Denver for Psilocybin, told Westword. “This one is our Hail Mary victory shot.”
Organizers in California recently attempted to get a psilocybin decriminalization initiative on the 2018 ballot, but that effort failed.
Photo courtesy of Wikimedia/Mädi.
Beto O’Rourke Slams Drug War And Police Killing Of Botham Jean At Dallas Event
Rep. Beto O’Rourke (D-TX), who is running for U.S. Senate this year, spoke before an animated crowd at a Baptist church in Dallas on Friday, decrying the war on drugs and calling for the end of marijuana prohibition.
The candidate, who’s made a strong showing in his race against incumbent Sen. Ted Cruz (R-TX), also commented on the recent killing of an unarmed black man, Botham Jean, at the hands of a Texas police officer.
“How can it be in this day and age—in this very year, in this community—that a young man, African American, in his own apartment, is shot and killed by a police officer?” O’Rourke asked. “And when we all want justice and the facts and the information to make an informed decision, what is released to the public? That he had a small amount of marijuana in his kitchen? How can that be just in this country?”
“How can we continue to lose the lives of unarmed black men in the United States of America at the hands of white police officers? That is not justice. That is not us. That can and must change. Are you with me on this?”
The audience responded with a resounding standing ovation.
See O’Rourke’s marijuana and criminal justice comments roughly 31 minutes into his Facebook video below:
O’Rourke spent several minutes outlining how the drug war disproportionately impacts communities of color despite the fact that white people use and sell drugs at roughly the same rate.
“It has kept people out of civic life in this country, it has kept them from their freedoms, it has kept them from democratic life in this country.”
Resolving racially discriminatory drug enforcement efforts starts with ending cannabis prohibition, O’Rourke said, noting that he co-sponsored congressional legislation that would do just that. But importantly, the second step is to expunge “the arrest records for anyone arrested for possession of marijuana so they can get on with their lives, live to their full potential, contribute to their maximum capacity.”
One of the congressman’s most salient points contrasted marijuana policies in Texas and fully legal states like California.
“Let me ask you this: in a country where the majority of the states in the union have already decided to make marijuana legal in one form or another—where people in California and Colorado and the Northwest are getting filthy rich legally selling marijuana today—who is going to be the last African American boy or man to rot behind bars in Texas for something that’s legal in almost every other single part of the country?”
“Let’s lead the way on reforming our drug laws,” O’Rourke said. “Let’s end that war on drugs right now because it’s a war on people.”
Cruz has attempted to frame his opponent’s drug reform stance as dangerous, promoting misleading statements attributed to O’Rourke in campaign ads and arguing that he’d exacerbate the opioid epidemic if elected in November.
With opioids ravaging so many American communities, Congressman Beto O’Rourke's radical resolution to legalize all narcotics—including heroin and other deadly opioids—is looking worse and worse all the time: https://t.co/VdwaYMccMn #TXSen
— Ted Cruz (@tedcruz) May 1, 2018
Which message will ultimately more resonant with Texas voters is yet to be determined—but the race is looking close.
Photo courtesy of Facebook/Beto O’Rourke.